How is iSolve Innovating Pharma with the Blockchain?

Date October 10, 2018

  By Managing their Use Cases with ADLT™ 3.0!!! As the pharmaceutical industry slowly embraces Blockchain technology, companies such as iSolve are tasked with the responsibility to incorporate new functionality into our solution to help support the various Business Units and Use Cases for global deployment and compliance. For this reason, iSolve is now releasing …

Advancing Patient Adherence: Leveraging Serialization & ADLT™ from Manufacturer to Patient

Date June 30, 2016

According to a 2014 Whitepaper by The ThomsenGroup, “.. non-adherence with prescription regimens is now a $300 billion problem in the US. The NCBI (National Center for Biotechnology Information )..noted that almost 50% of all prescribed medications are not taken according to directions…and nearly 25% are never initiated.” Non-adherence is problematic both from a National …

ADLT™ and Getting a handle on API Inventory

Recently, I spoke to a Pharma Company and asked them how much visibility they had into the manufacturing of APIs and other raw ingredients. The representative responded: “We don’t have any visibility into the API’s”. As with the rest of the supply chain, this lack of visibility has a significant impact on inventory levels and …

ADLT™: Creating Inventory Visibility – 4 Reasons Pharma Hangs On To Inventory So Long

The use of Advanced Digital Ledger Technology™ (ADLT™), of which the Blockchain is an example, can have a tremendous impact on improving the flow of information across the entire supply chain. It empowers biopharmaceutical manufacturers as they now have direct access to supply chain and patient level data without using third party vendors.   But …